The Times Australia
Google AI
News From Asia

.

HonKuwa, with Academician Yoshiki Sawa, Ushering in a New Era of Innovative Drug R & D.

TOKYO, JAPAN - Media OutReach Newswire - 15 October 2024 - HonKuwa Pharmaceutical Co., Ltd. officially announces a strategic partnership with Professor Yoshiki Sawa, a world-renowned expert in the field of regenerative medicine and an academician of the Engineering Academy of Japan.

Professor Sawa has been appointed as the honorary chief research scientist of HonKuwa. At the signing ceremony held at InterContinental Osaka, both parties jointly embark on a new chapter in the exploration of innovative drugs.

Caption

This cooperation is designed to combine Professor Sawa's outstanding research in cell biology and regenerative medicine with HonKuwa's cutting-edge product development capabilities, promoting innovative treatment solutions in the fields of joint and muscle injury repair. Professor Sawa stated, "I have been dedicated to regenerative science research and clinical practice. I look forward to closely integrating the latest technology in this field with HonKuwa's products and exploring how to better apply scientific and technological achievements in clinical settings to help more patients improve their health. I have full confidence in HonKuwa's team and expect to work together to transform scientific research results into practical health solutions."

HonKuwa Pharmaceutical Co., Ltd. was established in 2011 and is focused on the production and trade of health foods, medical products, and medical devices. Adhering to the business philosophy of "quality first, reputation supreme," it is committed to providing high-quality health products for global users. This cooperation marks an important step forward for HonKuwa in the field of global innovative drug research and development. Both sides will jointly contribute more groundbreaking scientific research results to the medical and health field.

Hashtag: #HonKuwa


The issuer is solely responsible for the content of this announcement.

About HonKuwa Pharmaceutical

Since its establishment, HonKuwa has been consistently dedicated to researching and producing health products with high quality standards, covering areas such as health foods, medical products, and medical devices. The company is committed to promoting the development of global health through continuous innovation and helping more people achieve a better quality of life.

Times Magazine

AI is failing ‘Humanity’s Last Exam’. So what does that mean for machine intelligence?

How do you translate ancient Palmyrene script from a Roman tombstone? How many paired tendons ...

Does Cloud Accounting Provide Adequate Security for Australian Businesses?

Today, many Australian businesses rely on cloud accounting platforms to manage their finances. Bec...

Freak Weather Spikes ‘Allergic Disease’ and Eczema As Temperatures Dip

“Allergic disease” and eczema cases are spiking due to the current freak weather as the Bureau o...

IPECS Phone System in 2026: The Future of Smart Business Communication

By 2026, business communication is no longer just about making and receiving calls. It’s about speed...

With Nvidia’s second-best AI chips headed for China, the US shifts priorities from security to trade

This week, US President Donald Trump approved previously banned exports[1] of Nvidia’s powerful ...

Navman MiVue™ True 4K PRO Surround honest review

If you drive a car, you should have a dashcam. Need convincing? All I ask that you do is search fo...

The Times Features

Evil Ray declares war on the sun

Australia's boldest sunscreen brand Australians love the sun. The sun doesn't love them back. Mela...

Resolutions for Renovations? What to do before renovating in 2026

Rolling into the New Year means many Aussies have fresh plans for their homes with renovat...

Designing an Eco Conscious Kitchen That Lasts

Sustainable kitchens are no longer a passing trend in Australia. They reflect a growing shift towa...

Why Sydney Entrepreneur Aleesha Naxakis is Trading the Boardroom for a Purpose-Driven Crown

Roselands local Aleesha Naxakis is on a mission to prove that life is a gift...

New Year, New Keys: 2026 Strategies for First Home Buyers

We are already over midway through January, and if 2025 was anything to go by, this year will be o...

How to get managers to say yes to flexible work arrangements, according to new research

In the modern workplace, flexible arrangements can be as important as salary[1] for some. For ma...

Coalition split is massive blow for Ley but the fault lies with Littleproud

Sussan Ley may pay the price for the implosion of the Coalition, but the blame rests squarely wi...

How to beat the post-holiday blues

As the summer holidays come to an end, many Aussies will be dreading their return to work and st...

One Nation surges above Coalition in Newspoll as Labor still well ahead, in contrast with other polls

The aftermath of the Bondi terror attacks has brought about a shift in polling for the Albanese ...